Cue Biopharma announces $30M private placement

Cue Biopharma (CUE) announced that it has entered into a securities purchase agreement with certain accredited investors for a private placement for gross proceeds of approximately $30M to Cue Biopharma, before placement agent fees and offering expenses. The PIPE financing is expected to close on or about May 4, subject to the satisfaction of customary closing conditions. Newbridge Securities Corporation is acting as placement agent for the PIPE financing.